These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 39087914)

  • 1. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.
    Westenberger A; Skrahina V; Usnich T; Beetz C; Vollstedt EJ; Laabs BH; Paul JJ; Curado F; Skobalj S; Gaber H; Olmedillas M; Bogdanovic X; Ameziane N; Schell N; Aasly JO; Afshari M; Agarwal P; Aldred J; Alonso-Frech F; Anderson R; Araújo R; Arkadir D; Avenali M; Balal M; Benizri S; Bette S; Bhatia P; Bonello M; Braga-Neto P; Brauneis S; Cardoso FEC; Cavallieri F; Classen J; Cohen L; Coletta D; Crosiers D; Cullufi P; Dashtipour K; Demirkiran M; de Carvalho Aguiar P; De Rosa A; Djaldetti R; Dogu O; Dos Santos Ghilardi MG; Eggers C; Elibol B; Ellenbogen A; Ertan S; Fabiani G; Falkenburger BH; Farrow S; Fay-Karmon T; Ferencz GJ; Fonoff ET; Fragoso YD; Genç G; Gorospe A; Grandas F; Gruber D; Gudesblatt M; Gurevich T; Hagenah J; Hanagasi HA; Hassin-Baer S; Hauser RA; Hernández-Vara J; Herting B; Hinson VK; Hogg E; Hu MT; Hummelgen E; Hussey K; Infante J; Isaacson SH; Jauma S; Koleva-Alazeh N; Kuhlenbäumer G; Kühn A; Litvan I; López-Manzanares L; Luxmore M; Manandhar S; Marcaud V; Markopoulou K; Marras C; McKenzie M; Matarazzo M; Merello M; Mollenhauer B; Morgan JC; Mullin S; Musacchio T; Myers B; Negrotti A; Nieves A; Nitsan Z; Oskooilar N; Öztop-Çakmak Ö; Pal G; Pavese N; Percesepe A; Piccoli T; Pinto de Souza C; Prell T; Pulera M; Raw J; Reetz K; Reiner J; Rosenberg D; Ruiz-Lopez M; Ruiz Martinez J; Sammler E; Santos-Lobato BL; Saunders-Pullman R; Schlesinger I; Schofield CM; Schumacher-Schuh AF; Scott B; Sesar Á; Shafer SJ; Sheridan R; Silverdale M; Sophia R; Spitz M; Stathis P; Stocchi F; Tagliati M; Tai YF; Terwecoren A; Thonke S; Tönges L; Toschi G; Tumas V; Urban PP; Vacca L; Vandenberghe W; Valente EM; Valzania F; Vela-Desojo L; Weill C; Weise D; Wojcieszek J; Wolz M; Yahalom G; Yalcin-Cakmakli G; Zittel S; Zlotnik Y; Kandaswamy KK; Balck A; Hanssen H; Borsche M; Lange LM; Csoti I; Lohmann K; Kasten M; Brüggemann N; Rolfs A; Klein C; Bauer P
    Brain; 2024 Aug; 147(8):2652-2667. PubMed ID: 39087914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.
    Cook L; Verbrugge J; Schwantes-An TH; Schulze J; Foroud T; Hall A; Marder KS; Mata IF; Mencacci NE; Nance MA; Schwarzschild MA; Simuni T; Bressman S; Wills AM; Fernandez HH; Litvan I; Lyons KE; Shill HA; Singer C; Tropea TF; Vanegas Arroyave N; Carbonell J; Cruz Vicioso R; Katus L; Quinn JF; Hodges PD; Meng Y; Strom SP; Blauwendraat C; Lohmann K; Casaceli C; Rao SC; Ghosh Galvelis K; Naito A; Beck JC; Alcalay RN
    Brain; 2024 Aug; 147(8):2668-2679. PubMed ID: 39074992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.
    Camargos ST; Dornas LO; Momeni P; Lees A; Hardy J; Singleton A; Cardoso F
    Mov Disord; 2009 Apr; 24(5):662-6. PubMed ID: 19205068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings.
    Skrahina V; Gaber H; Vollstedt EJ; Förster TM; Usnich T; Curado F; Brüggemann N; Paul J; Bogdanovic X; Zülbahar S; Olmedillas M; Skobalj S; Ameziane N; Bauer P; Csoti I; Koleva-Alazeh N; Grittner U; Westenberger A; Kasten M; Beetz C; Klein C; Rolfs A;
    Mov Disord; 2021 Apr; 36(4):1005-1010. PubMed ID: 33314351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
    Kessler C; Atasu B; Hanagasi H; Simón-Sánchez J; Hauser AK; Pak M; Bilgic B; Erginel-Unaltuna N; Gurvit H; Gasser T; Lohmann E
    Parkinsonism Relat Disord; 2018 Mar; 48():34-39. PubMed ID: 29248340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic study of early-onset Parkinson's disease in the Malaysian population.
    Tay YW; Tan AH; Lim JL; Lohmann K; Ibrahim KA; Abdul Aziz Z; Chin YT; Mawardi AS; Lim TT; Looi I; Chia YK; Ooi JCE; Cheah WK; Dy Closas AMF; Lit LC; Hor JW; Toh TS; Muthusamy KA; Bauer P; Skrahin V; Rolfs A; Klein C; Ahmad-Annuar A; Lim SY
    Parkinsonism Relat Disord; 2023 Jun; 111():105399. PubMed ID: 37209484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
    Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population.
    Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM
    J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Role of SNCA, LRRK2, and GBA in Chinese Patients With Early-Onset Parkinson's Disease.
    Chen Y; Gu X; Ou R; Zhang L; Hou Y; Liu K; Cao B; Wei Q; Li C; Song W; Zhao B; Wu Y; Cheng J; Shang H
    Mov Disord; 2020 Nov; 35(11):2046-2055. PubMed ID: 32677286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
    Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
    Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Parkinson disease patients from Portugal for mutations in SNCA, PRKN, PINK1 and LRRK2.
    Bras J; Guerreiro R; Ribeiro M; Morgadinho A; Januario C; Dias M; Calado A; Semedo C; Oliveira C; Hardy J; Singleton A
    BMC Neurol; 2008 Jan; 8():1. PubMed ID: 18211709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.
    Mellick GD; Siebert GA; Funayama M; Buchanan DD; Li Y; Imamichi Y; Yoshino H; Silburn PA; Hattori N
    Parkinsonism Relat Disord; 2009 Feb; 15(2):105-9. PubMed ID: 18486522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of genetic risk factors in Japanese patients with Parkinson's disease.
    Kanaya Y; Kume K; Morino H; Ohsawa R; Kurashige T; Kamada M; Torii T; Izumi Y; Maruyama H; Kawakami H
    J Hum Genet; 2021 Oct; 66(10):957-964. PubMed ID: 33742109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's Disease is Predominantly a Genetic Disease.
    Lim SY; Klein C
    J Parkinsons Dis; 2024; 14(3):467-482. PubMed ID: 38552119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease.
    Fernández-Santiago R; Martín-Flores N; Antonelli F; Cerquera C; Moreno V; Bandres-Ciga S; Manduchi E; Tolosa E; Singleton AB; Moore JH; ; Martí MJ; Ezquerra M; Malagelada C
    Mov Disord; 2019 Sep; 34(9):1333-1344. PubMed ID: 31234232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
    Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
    Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance.
    Lubbe SJ; Escott-Price V; Gibbs JR; Nalls MA; Bras J; Price TR; Nicolas A; Jansen IE; Mok KY; Pittman AM; Tomkins JE; Lewis PA; Noyce AJ; Lesage S; Sharma M; Schiff ER; Levine AP; Brice A; Gasser T; Hardy J; Heutink P; Wood NW; Singleton AB; Williams NM; Morris HR;
    Hum Mol Genet; 2016 Dec; 25(24):5483-5489. PubMed ID: 27798102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants of PARK genes in Korean patients with early-onset Parkinson's disease.
    Youn J; Lee C; Oh E; Park J; Kim JS; Kim HT; Cho JW; Park WY; Jang W; Ki CS
    Neurobiol Aging; 2019 Mar; 75():224.e9-224.e15. PubMed ID: 30502028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.